US Stock Reports, Quotes and News
Getinge AB (GETI B), a leading global provider of medical technology products and solutions, reported a 5.2% increase in sales for the first quarter of 2024, with a steady organic sales performance despite previous year's high comparative figures from COVID-19 impacts in China. The company's order intake rose by 7.8%, showing organic growth across all business areas and regions.
Novartis (SIX:NOVN) (NVSEF) shares surged 4.7% in European trading Tuesday after the Swiss pharmaceutical company's release of impressive first-quarter results.
On Tuesday, Renault reported a 1.8% increase in first-quarter revenue, driven by higher sales from its financing arm due to rising interest rates, and a 2.6% increase in car sales volumes compared to the previous year.
FNB Corporation (NYSE: FNB) has reported a strong first quarter, with operating earnings per share at $0.34 and operating net income of $123 million. The company has seen significant growth in its loan and deposit portfolios, along with a nearly record level of non-interest income, thanks to its strategic investments and geographic expansion. FNB\’s asset quality metrics remain robust, and the company is optimistic about the second half of the year, expecting to benefit from a more favorable interest rate environment. Despite some increases in operating non-interest expense and a slight decline in net interest margin, FNB maintains its full-year guidance and continues to receive recognition for its service and performance.
Johnson & Johnson (NYSE:JNJ) reported mixed financial results for the first quarter of 2024, with adjusted earnings per share (EPS) slightly surpassing analyst expectations, while revenue fell marginally short of estimates. The healthcare giant posted an adjusted EPS of $2.71, which was $0.07 higher than the consensus estimate of $2.64. However, quarterly revenue was a hair\’s breadth away from consensus, coming in at $21.38 billion against the expected $21.4 billion.